Press Releases August 27, 2026 03:00 PM

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Stryker to Present at 2026 Wells Fargo Healthcare Conference with Executive Fireside Chat

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation announced its participation in the 2026 Wells Fargo Healthcare Conference on September 8, 2026, featuring a fireside chat with key executives including the CFO and VP of Investor Relations. The event will be webcast live, allowing investors and interested parties to gain insights into the company's performance and strategy.

Stryker to participate in the 2026 Wells Fargo Healthcare Conference
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker will participate in the 2026 Wells Fargo Healthcare Conference with a session on September 8, 2026.
  • Top executives, including CFO Preston Wells and Investor Relations VP Nick Mead, will participate in a fireside chat.
  • The session will be webcast live and replayed for broader investor access.
  • The company is a global leader in medical technologies impacting MedSurg, Neurotechnology, and Orthopaedics sectors.

Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor.

Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. (Eastern time). A simultaneous live audio webcast and replay of the session can be accessed at Stryker - Events & Presentations.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com   

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com


Risks

  • The announcement does not include new product launches or financial results, limiting immediate market-moving information.
  • Market reaction could be subdued as the event is primarily informational and standard investor relations practice.
  • Broader healthcare sector uncertainties, such as regulatory or reimbursement changes, remain unaddressed.

More from Press Releases

Amid AI Boom, Verisk Launches New View of U.S. Data Center Exposure, Helping Insurers Assess Growing Concentrations of Risk Sep 3, 2026 Reborn Coffee Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements Sep 3, 2026 HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy Sep 3, 2026 LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China Sep 3, 2026 Ming Shing Group Holdings Limited Announces Closing of the Acquisition of Meals Through Seasons Limited and Issuance of Consideration Shares and Unsecured Convertible Promissory Notes Sep 2, 2026